Analyst Ratings For NASDAQ:SUPN – Supernus Pharmaceuticals (NASDAQ:SUPN)
Today, Stifel Nicolaus raised its price target on NASDAQ:SUPN – Supernus Pharmaceuticals (NASDAQ:SUPN) to per share.
Some recent analyst ratings include
- 2/1/2018-Berenberg Bank initiated coverage with a Buy rating.
- 1/18/2018-B. Riley Reiterated Rating of Buy ➝ Buy.
- 12/4/2017-Janney Montgomery Scott Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
- 11/3/2017-SunTrust Banks Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:SUPN – Supernus Pharmaceuticals (NASDAQ:SUPN)
NASDAQ:SUPN – Supernus Pharmaceuticals (NASDAQ:SUPN) has insider ownership of 6.20% and institutional ownership of 97.29%.
- On 5/15/2018 Padmanabh P Bhatt, VP, sold 7,868 with an average share price of $57.93 per share and the total transaction amounting to $455,793.24.
- On 5/11/2018 Padmanabh P Bhatt, VP, sold 67,132 with an average share price of $53.11 per share and the total transaction amounting to $3,565,380.52.
- On 4/19/2018 Victor Vaughn, VP, sold 17,850 with an average share price of $47.93 per share and the total transaction amounting to $855,550.50.
- On 4/5/2018 Victor Vaughn, VP, sold 60,000 with an average share price of $45.33 per share and the total transaction amounting to $2,719,800.00.
- On 1/22/2018 Padmanabh P Bhatt, VP, sold 20,000 with an average share price of $48.04 per share and the total transaction amounting to $960,800.00.
- On 1/17/2018 Padmanabh P Bhatt, VP, sold 20,000 with an average share price of $44.98 per share and the total transaction amounting to $899,600.00.
- On 1/12/2018 Victor Vaughn, VP, sold 5,750 with an average share price of $45.03 per share and the total transaction amounting to $258,922.50.
Recent Trading Activity for NASDAQ:SUPN – Supernus Pharmaceuticals (NASDAQ:SUPN)
Shares of NASDAQ:SUPN – Supernus Pharmaceuticals closed the previous trading session at 56.58 up +0.92 1.66% with shares trading hands.